Metabolic Disorder Drugs Research Reports & Market Industry Analysis

Metabolic Disorder Drugs Research

4 comprehensive market analysis studies and industry reports on the Metabolic Disorder Drugs sector, offering an industry overview with historical data since 2019 and forecasts up to 2029. This includes a detailed market research of 33 research companies, enriched with industry statistics, industry insights, and a thorough industry analysis

4 Metabolic Disorder Drugs Reports

Hyperkalemia Treatments Market

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific, Middle East and Africa, South America

Major Players: Sanofi S.A., Perrigo Company plc, CSL Limited (Vifor Pharma Management Ltd.), AstraZeneca, Ardelyx

Phenylketonuria Industry

Study Period: 2019 - 2029

Regions Covered: North America, Europe, Asia-Pacific

Major Players: BioMarin Pharmaceuticals, SOM Innovation Biotech SL , Homology Medicines Inc. , Censa Pharmaceuticals (PTC Therapeutics), Codexis Inc.

Lysosomal Storage Disease Treatment Market

Study Period: 2021 - 2029

Regions Covered: North America, Europe, Asia Pacific

Major Players: Pfizer Inc, Takeda Pharmaceutical Company Limited (Shire Plc), Sanofi (Genzyme Corporation), BioMarin, Johnson & Johnson (Actelion Pharmaceuticals Ltd)

United States Cardiometabolic Fixed-dose Combinations Market

Study Period: 2019 - 2029

Country Covered: United States

Major Players: Merck & Co., Inc., AstraZeneca, Pfizer Inc., Novo Nordisk A/S, Sanofi

Interact With Data Points To Access Key Markets In The Healthcare Industry

Thank you!

Get Free Sample Of This Report

Metabolic Disorder Drugs Research

Categories

Related Metabolic Disorder Drugs Reports

Interact With Data Points To Access Key Markets In The Healthcare Industry

Geo Focus

Growth Rate

Thank you!

Get Free Sample Of This Report

Metabolic Disorder Drugs Research

Categories

Related Metabolic Disorder Drugs Reports